v3.26.1
Revenue - Additional information (Details)
€ in Thousands
12 Months Ended
Dec. 31, 2025
EUR (€)
customer
Dec. 31, 2024
EUR (€)
customer
Dec. 31, 2023
EUR (€)
customer
Transaction price      
Revenue from contracts with customers € 777,079 € 782,517 € 772,009
Contract assets 28,295 46,034 25,000
Current contract liabilities 104,849 106,599 97,587
Accumulated impairment      
Transaction price      
Contract assets 0 0  
Just - Evotec Biologics      
Transaction price      
Revenue from contracts with customers 259,443 183,431 107,493
Discovery & Preclinical Development      
Transaction price      
Revenue from contracts with customers € 517,636 € 599,086 € 664,516
Major customers      
Transaction price      
Number of major customers | customer 2 2 1
Revenue from contracts with customers € 292,314 € 256,691 € 195,386
Major customers | Just - Evotec Biologics      
Transaction price      
Revenue from contracts with customers 153,262 90,995  
Major customers | Discovery & Preclinical Development      
Transaction price      
Revenue from contracts with customers € 139,052 € 165,696 € 195,386
Major customers | Minimum      
Transaction price      
Percentage of entity's revenue 10.00% 10.00% 10.00%
Largest customer      
Transaction price      
Contract liabilities € 214,985 € 215,108  
Current contract liabilities 73,099 57,862  
In the course of the following year      
Transaction price      
Transaction price allocated to the remaining performance obligation 258,618 460,835 € 571,825
After one year      
Transaction price      
Transaction price allocated to the remaining performance obligation € 190,240 € 885,577 € 335,427